Hagino, H., Yoshida, S., Hashimoto, J., Matsunaga, M., Tobinai, M., & Nakamura, T. (2014). Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study. Calcif Tissue Int.
Citação norma ChicagoHagino, Hiroshi, Seitaro Yoshida, Junko Hashimoto, Masayuki Matsunaga, Masato Tobinai, and Toshitaka Nakamura. "Increased Bone Mineral Density With Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients With Primary Osteoporosis: Three-Year Analysis of the MOVER Study." Calcif Tissue Int 2014.
ציטוט MLAHagino, Hiroshi, et al. "Increased Bone Mineral Density With Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients With Primary Osteoporosis: Three-Year Analysis of the MOVER Study." Calcif Tissue Int 2014.